Australia Pharmaceuticals and Healthcare Report Q1 2010

Executive Summary ......................5
SWOT Analysis..............................6
Australia Pharmaceuticals And Healthcare Industry SWOT .............. 6
Australia Political SWOT ............................. 7
Australia Economic SWOT ........................... 7
Australia Business Environment SWOT........ 8
Pharmaceutical Business Environment Ratings ..............9
Table: Asia Pharmaceuticals Business Environment Ratings, Q110 ... 9
Limits of Potential Returns ......................... 10
Risks to Realisation of Returns ................... 10
Australia - Market Summary.......12
Regulatory Regime......................14
Table: Priorities Of the Therapeutic Goods Administrations Strategic Plan, 2006-2008 ........ 14
OTC Switching Climate .............................. 15
Regional Regulatory Harmonisation .......... 16
Recent Regulatory Developments ............... 16
Intellectual Property Issues ........................ 18
Trade Agreements....................................... 19
Pricing and Reimbursement........................ 20
Table: Historical PBS Co-payments ........... 21
Price Cuts ............. 22
Additions to Reimbursed Drugs List ........... 24
Recent Pricing and Reimbursement Developments........................... 25
Table New PBS Formularies....................... 25
Industry Trends and Developments.................................27
Epidemiology........ 27
Mental Health Issues .................................. 29
Healthcare Reforms .................................... 31
E-Health ............... 33
Healthcare Expenditure.............................. 34
Prescribing Patterns................................... 35
Private Healthcare Insurance..................... 36
Domestic Pharmaceutical Sector................ 37
Domestic Pharmaceutical Sector Developments............................... 37
Foreign Industry ......................................... 38
Retail Pharmacy Sector .............................. 39
Biotechnology and Research....................... 41
Clinical Trials....... 43
Medical Devices.......................................... 44
Table Examples Of Medical Devices Classifications ........................ 44
Recent Developments in the Medical Devices Sector........................ 45
Industry Forecast Scenario .........47
Overall Market Forecast............................. 47
Key Growth Factors – Industry................... 49
Key Growth Factors – Macroeconomic ...... 51
Table: Australia – Economic Activity, 2006-2013 ............................ 52
Prescription Market Forecast ..................... 53
Patented Product Market Forecast ............. 54
Generic Drug Market Forecasts ................. 55
OTC Medicine Market Forecast ................. 57
Pharmacy OTC Medicine Sales In Australia (US$), 2008 ................ 58
Pharmaceutical Trade Forecast ................. 59
Other Healthcare Data Forecasts............... 61
Key Risks to BMI’s Forecast Scenario........ 62
Competitive Landscape..............63
Company Profiles........................64
Leading Multinationals .............................. 64
Pfizer .................... 64
Sanofi-Aventis....... 66
GlaxoSmithKline......................................... 68
Merck Sharp & Dohme (Australia)............. 71
Indigenous Manufacturers ......................... 74
Sigma Pharmaceuticals .............................. 74
Australian Pharmaceutical Industries......... 77
Alphapharm (incorporated into Mylan) ...... 79
Herron Pharmaceuticals............................. 81
Mayne Pharma (Hospira) ........................... 83
CSL....................... 85
BMI Methodology ........................87
How We Generate Our Pharmaceutical Industry Forecasts ............. 87
Pharmaceutical Business Environment Ratings Methodology.......... 88
Ratings Overview........................................ 88
Table: Pharmaceutical Business Environment Indicators ................ 89
Weighting.............. 90
Table: Weighting Of Components............... 90
Sources................. 90
Forecast Tables ...........................91